U.S. pharma huge copyright scrapped two experimental weight loss pills last yr—a when-day by day capsule, lotiglipron, on account of elevated liver enzymes in addition to a two times-day by day capsule, danuglipron, on account of solid side effects—but CEO Albert Bourla has explained